Prescription Opioid Misuse Associated With Risk Behaviors Among Adolescents

Clayton, Heather B.; Bohm, Michele K.; Lowry, Richard; Ashley, Carmen; Ethier, Kathleen A.

doi:10.1016/j.amepre.2019.05.017

Cited by 50 publications

(25 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Therefore, all demographic and substance use variables were included in a single model to examine the independent effect of each variable on current prescription opioid misuse. This modeling strategy is consistent with previous research examining substance use behaviors among youths (6).…”

Section: Discussionsupporting

confidence: 85%

“…Beyond the individual negative effects of substance use during youth and into adulthood, substance use among youths also increases the likelihood for negative consequences that affect peers, families, and communities (5). Youth substance use is associated with increased risk for delinquency, academic underachievement, teenage pregnancy, sexually transmitted diseases, perpetrating or experiencing violence, injuries, and mental health problems (1,(3)(4)(5)(6).…”

Section: Introductionmentioning

confidence: 99%

“…As the United States confronts its decades-long opioid overdose epidemic (1,2), preventing opioid misuse among youth is a public health imperative. Previous research has documented that misuse of prescription opioids among youths is associated with multiple adverse health outcomes and risk behaviors, including use of alcohol and other illicit drugs, injection drug use, suicidal ideation, youth violence, delinquency, having four or more lifetime sexual partners, not using a condom at last sexual intercourse, increased risk for acquisition of human immunodeficiency virus infection and sexually transmitted diseases (6), and increasing overdoses (7). Studies also have demonstrated that prescription opioid misuse among youths is strongly linked with subsequent initiation and use of heroin and increased risk for injecting prescription opioids and developing an opioid use disorder (8)(9)(10).…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Prescription Opioid Misuse and Use of Alcohol and Other Substances Among High School Students — Youth Risk Behavior Survey, United States, 2019

Jones¹,

Clayton²,

Deputy³

et al. 2020

MMWR Suppl.

Self Cite

182

View full text Add to dashboard Cite

Adolescence is an important period of risk for substance use initiation and substance use-related adverse outcomes. To examine youth substance use trends and patterns, CDC analyzed data from the 2009-2019 Youth Risk Behavior Survey. This report presents estimated prevalence of current (i.e., previous 30-days) marijuana use, prescription opioid misuse, alcohol use, and binge drinking and lifetime prevalence of marijuana, synthetic marijuana, cocaine, methamphetamine, heroin, injection drug use, and prescription opioid misuse among U.S. high school students. Logistic regression and Joinpoint analyses were used to assess 2009-2019 trends. Prevalence of current and lifetime substance use by demographics, frequency of use, and prevalence of co-occurrence of selected substances among students reporting current prescription opioid misuse are estimated using 2019 data. Multivariable logistic regression analysis was used to determine demographic and substance use correlates of current prescription opioid misuse. Current alcohol, lifetime cocaine, methamphetamine, heroin, and injection drug use decreased during 2009-2019. Lifetime use of synthetic marijuana (also called synthetic cannabinoids) decreased during 2015-2019. Lifetime marijuana use increased during 2009-2013 and then decreased during 2013-2019. In 2019, 29.2% reported current alcohol use, 21.7% current marijuana use, 13.7% current binge drinking, and 7.2% current prescription opioid misuse. Substance use varied by sex, race/ethnicity, grade, and sexual minority status (lesbian, gay, or bisexual). Use of other substances, particularly current use of alcohol (59.4%) and marijuana (43.5%), was common among students currently misusing prescription opioids. Findings highlight opportunities for expanding evidence-based prevention policies, programs, and practices that aim to reduce risk factors and strengthen protective factors related to youth substance use, in conjunction with ongoing initiatives for combating the opioid crisis.

show abstract

Section: Discussionsupporting

confidence: 85%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Prescription Opioid Misuse and Use of Alcohol and Other Substances Among High School Students — Youth Risk Behavior Survey, United States, 2019

Jones¹,

Clayton²,

Deputy³

et al. 2020

MMWR Suppl.

Self Cite

182

View full text Add to dashboard Cite

show abstract

“…Factors previously found to be associated with adult and adolescent prescription opioid medical use and misuse 5,[20][21][22][23][24][25][26][27][28][29][30][31][32][33][34][35][36][37] were included as covariates in the models. These variables, defined in eMethods 2 in the Supplement, included parental past 12-month use of prescription benzodiazepines, stimulants, tobacco, alcohol, marijuana, and other illicit drugs; parents' and adolescents' perceived harm due to drug use, depression, delinquency, and physical health; adolescents' report of the quality of the parent-adolescent relationship, perceived schoolmates' drug use, and religiosity; and…”

Section: Covariatesmentioning

confidence: 99%

Assessment of Prescription Opioid Medical Use and Misuse Among Parents and Their Adolescent Offspring in the US

Griesler

Wall

et al. 2021

JAMA Netw Open

View full text Add to dashboard Cite

show abstract

“…High risk sexual behaviors in this population also lead to sexually transmitted infections and/or unintended pregnancy. Almost nine in 10 pregnancies in adults with OUD are unintended, and it is prudent to anticipate similar prevalence among youths [6].…”

Section: Introductionmentioning

confidence: 99%

San Bernardino County Youth Opioid Response: Improving Access to Evidence-Based Medical Treatment for Opioid Use Disorder

Neeki

Dong

Archambeau

et al. 2020

Cureus

View full text Add to dashboard Cite

Opioid use disorder (OUD) and related overdose deaths have become a crisis of epidemic proportions in the United States. In 2018, over 10 million people age 12 years or older misused opioids. Substance use is also correlated with increased physical and mental health disorders, and developmental challenges among youths. Medication-assisted treatment (MAT) has been reported to reduce mortality, opioid use, and human immunodeficiency virus and hepatitis C virus transmission while increasing treatment retention in adults. The San Bernardino County Youth Opioid Response (SBCYOR) program was formed to explore best practices for youths at risk of opioid use disorders and/or overdose. SBCYOR is a coalition of professionals in healthcare, behavioral health, public education, law enforcement, emergency medical services (EMS) agencies, and juvenile detention centers throughout San Bernardino County, California. SBCYOR focuses on high-risk and addicted individuals between the ages of 12 to 24 years in San Bernardino County's correctional system. It utilizes a strategy of collaboration, prevention, risk mitigation, medication, psychological treatment, and community outreach. This study aimed to evaluate the implementation and progress of SBCYOR.

show abstract

Prescription Opioid Misuse Associated With Risk Behaviors Among Adolescents

Cited by 50 publications

References 19 publications

Prescription Opioid Misuse and Use of Alcohol and Other Substances Among High School Students — Youth Risk Behavior Survey, United States, 2019

Prescription Opioid Misuse and Use of Alcohol and Other Substances Among High School Students — Youth Risk Behavior Survey, United States, 2019

Assessment of Prescription Opioid Medical Use and Misuse Among Parents and Their Adolescent Offspring in the US

San Bernardino County Youth Opioid Response: Improving Access to Evidence-Based Medical Treatment for Opioid Use Disorder

Contact Info

Product

Resources

About